Abrams S E, Walsh K P, Coker S J, Clarkson M J
Department of Pharmacology and Therapeutics, University of Liverpool.
Br Heart J. 1995 Feb;73(2):177-81. doi: 10.1136/hrt.73.2.177.
Nitric oxide is a potent dilator of the pulmonary vasculature. There have been no previous reports on the action of nitric oxide on the arterial duct.
To determine the responses of isolated post-term arterial duct rings from lambs to oxygen, prostaglandin E2 (PGE2) and the nitric oxide donor, 3-morpholinosydnonimine (SIN-1).
Experimental laboratory.
Six neonatal lambs.
Lambs aged 1-5 days were killed and the arterial duct and aorta excised and cut into rings. These were mounted on tension gauges in organ baths containing Krebs-Henseleit solution. Rings were exposed to increasing concentrations of oxygen, PGE2 and after preconstriction with potassium (40 mmol/l) to SIN-1. Tension and relaxation responses were recorded.
Increased oxygen tension resulted in increased tension in the ductal rings above 88.9 mm Hg as previously described. No response to PGE2 occurred before or after ductal rings were exposed to oxygen. SIN-1 caused relaxation of smooth muscle in the arterial duct to a similar degree as that in the aortic rings.
As previously shown, oxygen is a potent constrictor of the arterial duct. The post-term arterial duct does not relax in response to PGE2 possibly as a result of inactivation by oxygen of the special sensitivity of the duct to PGE2. SIN-1 is a potent smooth muscle relaxing agent in the term arterial duct and may have a role in the initial management of neonates with duct dependent pulmonary circulation.
一氧化氮是肺血管系统的强效扩张剂。此前尚无关于一氧化氮对动脉导管作用的报道。
确定来自羔羊的离体过期动脉导管环对氧气、前列腺素E2(PGE2)和一氧化氮供体3 - 吗啉代 sydnonimine(SIN - 1)的反应。
实验实验室。
六只新生羔羊。
处死1 - 5日龄的羔羊,切除动脉导管和主动脉并切成环。将这些环安装在含有 Krebs - Henseleit 溶液的器官浴中的张力计上。使环暴露于浓度递增的氧气、PGE2,并在先用钾(40 mmol/l)预收缩后再暴露于SIN - 1。记录张力和舒张反应。
如前所述,氧分压升高导致导管环张力在88.9 mmHg以上增加。在导管环暴露于氧气之前或之后,对PGE2均无反应。SIN - 1使动脉导管中的平滑肌舒张程度与主动脉环中的相似。
如先前所示,氧气是动脉导管的强效收缩剂。过期动脉导管对PGE2无舒张反应,可能是由于导管对PGE2的特殊敏感性被氧气灭活所致。SIN - 1是足月动脉导管中强效的平滑肌舒张剂,可能在依赖导管的肺循环新生儿的初始治疗中发挥作用。